Previous Article | Next Article ![]()
J. Virol., Jul 1996, 4275-4282, Vol 70, No. 7
RJ Fingerote, M Abecassis, MJ Phillips, YS Rao, EH Cole, J Leibowitz and GA Levy
Activation of the immune coagulation system has been implicated in the
pathogenesis of liver injury following infection of inbred mice with murine
hepatitis virus strain 3 (MHV-3). Following MHV-3 infection, macrophages
isolated from MHV-3-susceptible and -semisusceptible inbred strains of mice
express increased procoagulant activity (PCA), whereas macrophages from
resistant strains express no increase in PCA over basal levels. The PCA
induced by MHV-3 is a prothrombinase, encoded by the gene Fgl-2, which
encodes a fibrinogen-like protein (musfiblp). In this study,
MHV-3-resistant A/J mice treated with methylprednisolone prior to infection
with MHV-3 developed elevated levels of alanine aminotransferase in serum
and died within 10 days of infection, with histological findings of
fulminant hepatitis. In vitro, macrophages isolated from A/J mice and
pretreated with methylprednisolone produced a marked increase in functional
PCA following infection with MHV-3. The PCA was shown to be a
prothrombinase by its ability to cleave 125I- prothrombin. Northern blot
analysis of RNA transcripts from these macrophages demonstrated increased
transcription of the Fgl-2 gene relative to that in macrophages which had
not been pretreated with methylprednisolone prior to MHV-3 infection.
Methylprednisolone pretreatment of MHV-3-infected macrophages stabilized
the Fgl-2 mRNA. Thus, loss of resistance to MHV-3 secondary to
methylprednisolone therapy is associated with increased transcription and
stability of Fgl- 2 mRNA resulting in expression of the Fgl-2 gene product,
musfiblp. These results provide further insight into mechanisms of PCA
regulation in response to MHV-3 infection in inbred strains of mice.
Copyright © 1996, American Society for Microbiology
Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity
Department of Medicine, Toronto Hospital, University of Toronto, Ontario, Canada.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|